Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-22-020890

← back to feed
Filed
Aug 1, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 978.78M sh
Current Liabilities Q2 2022 · Jun 30, 2022 $9.12M
Current Liabilities Q2 2022 · Dec 31, 2021 $8.16M
Total Liabilities Q2 2022 · Jun 30, 2022 $9.21M
Total Liabilities Q2 2022 · Dec 31, 2021 $8.32M
Current Assets Q2 2022 · Jun 30, 2022 $4.83M
Current Assets Q2 2022 · Dec 31, 2021 $2.37M
Total Assets Q2 2022 · Jun 30, 2022 $5.44M
Total Assets Q2 2022 · Dec 31, 2021 $3.02M
Capex Q2 2022 · Jun 30, 2021 $5.12K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$966.81K
Stockholders Equity Q2 2022 · Jun 30, 2021 −$5.02M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$6.88M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$6.57M
Eps Basic Q2 2022 · Jun 30, 2021 $0.00
Eps Basic Q2 2022 · Jun 30, 2021 $0.00
Sga Expense Q2 2022 · Jun 30, 2021 $369.31K
Sga Expense Q2 2022 · Jun 30, 2021 $675.9K
Rd Expense Q2 2022 · Jun 30, 2021 $44.73K
Rd Expense Q2 2022 · Jun 30, 2021 $132.49K
Net Income Q2 2022 · Jun 30, 2021 −$2.75M
Net Income Q2 2022 · Jun 30, 2021 −$3.69M
Operating Income Q2 2022 · Jun 30, 2021 −$705.18K
Operating Income Q2 2022 · Jun 30, 2021 −$1.37M